Spacelabs gets twin OKs from FDA
Spacelabs has been cleared to sell two new products in the U.S., an anesthesia system and a compact patient monitor.
The Issaquah, Wash.-based manufacturer announced FDA 510(k) clearance on its Arkon anesthesia delivery system and its qube monitor.
Spacelabs said Arkon uses a “combination of innovative technology and ergonomics not previously available in the perioperative environment” while the qube is mountable on bedrails and anesthesia machines as well as walls, and can be detached via a quick-release feature.
The company rolled out the new market offerings in Buenos Aires March 25 to 30 at the World Congress of Anesthesiologists, where it also introduced an open-platform anesthesia system called BleaseFocus and a line of telemetry transmitters, AriaTele.
Spacelabs is a wholly owned subsidiary of OSI Systems in Hawthorne, Calif., founded and headed by “the other” Deepak Chopra.
The Issaquah, Wash.-based manufacturer announced FDA 510(k) clearance on its Arkon anesthesia delivery system and its qube monitor.
Spacelabs said Arkon uses a “combination of innovative technology and ergonomics not previously available in the perioperative environment” while the qube is mountable on bedrails and anesthesia machines as well as walls, and can be detached via a quick-release feature.
The company rolled out the new market offerings in Buenos Aires March 25 to 30 at the World Congress of Anesthesiologists, where it also introduced an open-platform anesthesia system called BleaseFocus and a line of telemetry transmitters, AriaTele.
Spacelabs is a wholly owned subsidiary of OSI Systems in Hawthorne, Calif., founded and headed by “the other” Deepak Chopra.
Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.